Yeah I would not want to be the one to design that clinical trial. The slower moving a disease, the more difficult it is to test if something is having an effect on it. Nothing slower than aging.
The Framingham Heart Study has entered the chat. It’s really the only way to assess a longitudinal effect of this kind.
“Whether this translates to human biology, or is a potential risk to our health, is a topic of ongoing debate”
That sounds like a brand name. What’s the actual chemical?
It is the actual chemical name. There’s probably a very long generic name describing the molecule, too.
Rilmenidine is a prescription medication for the treatment of hypertension. It is marketed under the brand names Albarel, Hyperium, Iterium and Tenaxum.
Rilmenidine dihydrogen phosphate.
